+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Travel Vaccines Market 2018-2022 - Product Image

Global Travel Vaccines Market 2018-2022

  • ID: 4721317
  • Report
  • Region: Global
  • 118 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Valneva
  • MORE
Increased incidence of travel-related diseases is expected to drive the market growth. Traveling is often associated with higher health risks especially regarding infectious diseases. Thus, the rising incidence of travel related diseases will lead to more investments in the global travel vaccines market for the development of more effective vaccines. The analysts have predicted that the travel vaccines market will register a CAGR of almost 10% by 2022.

Market Overview

Increase in global travel and migration

With the rise in traveling over the past few years has resulted in the spread of pathogens and disease-causing vectors worldwide. The increase in travel and migration offers huge opportunities to the manufacturers to invest in the R&D of new and more effective vaccines.

High cost of travel vaccinations

Travel clinics offer vaccinations at a slightly higher price and new vaccines are usually more expensive.

For the detailed list of factors that will drive and challenge the growth of the travel vaccines market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Sanofi and Valneva, the competitive environment is quite intense. Factors such as the increased incidence of travel-related diseases and the increase in global travel and migration, will provide considerable growth opportunities to travel vaccines manufactures. GlaxoSmithKline, Pfizer, Sanofi, and Valneva are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Valneva
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: PIPELINE ANALYSIS
  • Pipeline analysis
PART 06: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 08: MARKET SEGMENTATION BY TARGET DISEASE FOR IMMUNIZATION
  • Segmentation by target disease for immunization
  • Comparison by target disease for immunization
  • Influenza - Market size and forecast 2017-2022
  • Diphtheria - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Hepatitis - Market size and forecast 2017-2022
  • Typhoid - Market size and forecast 2017-2022
  • Polio - Market size and forecast 2017-2022
  • Yellow fever - Market size and forecast 2017-2022
  • Market opportunity by target disease
PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity by region
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Changes in the demographic profile of travelers globally
  • Increased incidence of travel-related diseases
  • Initiatives by governments and other organizations to ensure travel safety
  • Evolving epidemiological patterns of infectious diseases in different countries
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Valneva
PART 16: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global human vaccines market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pipeline Vaccines Under Phase III Development
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global - Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global - Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2017
Exhibit 19: Target disease for immunization - Market share 2017-2022 (%)
Exhibit 20: Comparison by target disease for immunization
Exhibit 21: Influenza - Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Influenza - Year-over-year growth 2018-2022 (%)
Exhibit 23: Diphtheria - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Diphtheria - Year-over-year growth 2018-2022 (%)
Exhibit 25: Others - Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Others - Year-over-year growth 2018-2022 (%)
Exhibit 27: Hepatitis - Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Hepatitis - Year-over-year growth 2018-2022 (%)
Exhibit 29: Typhoid - Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Typhoid - Year-over-year growth 2018-2022 (%)
Exhibit 31: Polio - Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Polio - Year-over-year growth 2018-2022 (%)
Exhibit 33: Yellow fever - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Yellow fever - Year-over-year growth 2018-2022 (%)
Exhibit 35: Market opportunity by target disease for immunization
Exhibit 36: Customer landscape
Exhibit 37: Global - Market share by geography 2017-2022 (%)
Exhibit 38: Regional comparison
Exhibit 39: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 40: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 41: Top 3 countries in Americas
Exhibit 42: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 43: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 44: Top 3 countries in EMEA
Exhibit 45: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 46: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 47: Top 3 countries in APAC
Exhibit 48: Market opportunity
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendors covered
Exhibit 52: Vendor classification
Exhibit 53: Market positioning of vendors
Exhibit 54: GlaxoSmithKline - Overview
Exhibit 55: GlaxoSmithKline - Business segments
Exhibit 56: GlaxoSmithKline - Organizational developments
Exhibit 57: GlaxoSmithKline - Geographic focus
Exhibit 58: GlaxoSmithKline - Segment focus
Exhibit 59: GlaxoSmithKline - Key offerings
Exhibit 60: Pfizer - Overview
Exhibit 61: Pfizer - Business segments
Exhibit 62: Pfizer - Organizational developments
Exhibit 63: Pfizer - Geographic focus
Exhibit 64: Pfizer - Segment focus
Exhibit 65: Pfizer - Key offerings
Exhibit 66: Sanofi - Overview
Exhibit 67: Sanofi - Business segments
Exhibit 68: Sanofi - Organizational developments
Exhibit 69: Sanofi - Geographic focus
Exhibit 70: Sanofi - Segment focus
Exhibit 71: Sanofi - Key offerings
Exhibit 72: Valneva - Overview
Exhibit 73: Valneva- Business segments
Exhibit 74: Valneva - Organizational developments
Exhibit 75: Valneva - Geographic focus
Exhibit 76: Valneva - Key offerings
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Valneva
  • MORE
Global Travel Vaccines Market 2018-2022

The analyst recognizes the following companies as the key players in the global travel vaccines market: GlaxoSmithKline, Pfizer, Sanofi, and Valneva.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increased incidence of travel-related diseases.”

According to the report, one of the major drivers for this market is the increase in global travel and migration

Further, the report states that one of the major factors hindering the growth of this market is the high cost of travel vaccinations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Valneva
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4721317
Adroll
adroll